Trial Profile
A Prospective, Randomized, Open-label, Active-controlled Study to Evaluate the Efficacy and Safety of Fosamax Plus D in Postmenopausal Osteoporotic Women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Alendronic acid/colecalciferol (Primary) ; Alendronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Organon
- 07 Apr 2010 Patient numbers amended from 350 to 343 as reported by ClinicalTrials.gov.
- 05 Jun 2009 Actual initiation date changed from Mar 2008 to Apr 2008 as reported by ClinicalTrials.gov.
- 13 May 2009 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov